Question 1

What does peer-reviewed research say about these claims?

Accepted Answer

Bro translation: Mainstream medical consensus does not support the claim that a 'sluggish liver' is a primary cause or closely associated driver of hypothyroidism; hypothyroidism is overwhelmingly caused by autoimmune destruction (Hashimoto's), iodine deficiency, or medication side effects, not liver detoxification capacity. Furthermore, the concept of 'sub-optimal' liver function that evades standard blood tests (AST, ALT, bilirubin) is not supported by evidence; standard liver function tests are highly sensitive for detecting actual liver pathology, and the 'sub-optimal' diagnosis is a functional medicine construct used to justify unproven testing and supplements.

Question 2

Are Jaban M Moore's credentials legitimate?

Accepted Answer

No specific credentials listed in this clip; channel name 'Redefining Wellness Center' implies a functional medicine or naturopathic background, but the clip itself does not establish licensure. Stated credentials: none detected. Likely credentials: Chiropractor (DC), DC. Credential inflation detected, a white coat is not the same as an MD/DO license.

Question 3

Is Dr Jaban M Moore a real medical doctor?

Accepted Answer

Jaban M Moore is not identified as an MD/DO physician in reviewed credentials or public registry data. Likely credential: Chiropractor (DC).

Question 4

Does Jaban M Moore use Fear Mongering?

Accepted Answer

Invents a hidden disease state ('sub-optimal') that standard medical tests miss, creating anxiety to sell unproven liver support protocols. Likely motive: Drive traffic to 'virtual clinic' for paid consultations and supplement sales.

Question 5

Does Jaban M Moore use False Authority?

Accepted Answer

Uses 'our experience' (anecdotal) to claim a causal link between a vague functional concept ('sluggish liver') and a serious autoimmune/endocrine disease (hypothyroidism), bypassing peer-reviewed evidence. Likely motive: Position the clinic as the sole expert on 'root cause' thyroid issues.

Question 6

Is the claim "A sluggish liver is closely associated with hypothyroidism" supported by medical literature?

Accepted Answer

The index meta-analysis on hypothyroidism and liver fibrosis reports that higher TSH and subclinical hypothyroidism are associated with increased risk of significant liver fibrosis and advanced fibrosis in NAFLD patients, and overt hypothyroidism is associated with higher NASH risk, indicating a clinically relevant link between hypothyroid status and more severe chronic liver disease. The meta-analysis on subclinical hypothyroidism and NAFLD finds that subclinical hypothyroidism modestly but significantly increases the odds of NAFLD, supporting a statistical association between thyroid underactivity and fatty liver. Another systematic review and meta-analysis concludes that nonalcoholic fatty liver disease is not associated with thyroid hormone levels and hypothyroidism overall, but this negative finding itself demonstrates that the hypothyroid–liver relationship has been rigorously examined in large pooled datasets. Additional systematic reviews and meta-analyses from the broader literature consistently report that hypothyroidism (overt or subclinical) is associated with a higher prevalence of NAFLD and with greater histologic severity once NAFLD is present, and reviews of thyroid–liver interactions describe bidirectional physiological links, including thyroid hormone regulation of hepatic lipid metabolism and hepatic metabolism of thyroid hormones. These bodies of evidence together support that hypothyroidism and chronic liver conditions, especially NAFLD and its progression, are epidemiologically and mechanistically connected, though mostly via metabolic pathways rather than a vague notion of “sluggish liver.” The systematic review and meta-analysis in the European Thyroid Journal explicitly concludes that nonalcoholic fatty liver disease is not associated with thyroid hormone levels and hypothyroidism when pooling available data, contradicting a simple or universal association between hypothyroidism and fatty liver. The NAFLD–thyroid literature overall is heterogeneous: some meta-analyses and systematic reviews report a positive association, whereas others report null findings or only weak, confounded associations, indicating that the strength and consistency of the relationship are limited and likely influenced by obesity, insulin resistance, and other metabolic factors rather than hypothyroidism alone. Existing studies are predominantly observational (cross-sectional or cohort) rather than interventional, so they cannot determine whether hypothyroidism causes a “sluggish” liver or vice versa; causality and directionality remain uncertain. Major trials and guidelines do not use or recognize “sluggish liver” as a diagnostic category, and there is no high-quality evidence that treating mild hypothyroidism directly “fixes” liver sluggishness independent of weight loss, improved diet, or better metabolic control. Overall, the evidence base does not support the influencer-style implication that a vaguely defined sluggish liver is closely or uniquely associated with hypothyroidism across the general population; instead, it supports a more modest, metabolically mediated association in specific liver diseases such as NAFLD and NASH, with important negative studies and conflicting results tempering any strong causal claim. Mainstream endocrinology and hepatology recognize a bidirectional, metabolically mediated relationship between thyroid dysfunction and liver disease, especially that overt and subclinical hypothyroidism are epidemiologically associated with higher prevalence and greater severity of NAFLD and related fibrosis, but they do not endorse “sluggish liver” as a medical diagnosis. The consensus from systematic reviews and guidelines is that hypothyroidism is one of several metabolic risk factors that can contribute to fatty liver and fibrosis and that liver disease can, in turn, alter thyroid hormone metabolism, yet this relationship is neither exclusive nor invariably present and is strongly confounded by obesity, dyslipidemia, and insulin resistance. Clinicians therefore screen selectively for thyroid dysfunction in patients with unexplained liver abnormalities or NAFLD and manage hypothyroidism according to standard indications, with the understanding that thyroid treatment may modestly improve liver-related metabolic parameters but is not a primary or standalone therapy for liver disease. In everyday medical practice, hypothyroidism is viewed as a contributory factor in certain chronic liver diseases, not as a condition that is intrinsically or universally “closely associated” with a catch-all entity like a sluggish liver; the preferred framing is specific, evidence-based diagnoses such as NAFLD, NASH, and liver fibrosis rather than vague functional labels. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). Literature verdict: mixed.

Question 7

Is the claim "Your doctor may have told you your liver function is fine, but it can still be operatin…" supported by medical literature?

Accepted Answer

Normal liver tests do not fully exclude liver disease or impaired hepatic function, and major guidance notes that normal ALT may not exclude significant liver disease, with routine liver blood tests sometimes normal even in advanced disease. Clinical reviews also emphasize that routine “liver function tests” are often markers of injury rather than direct measures of function, and that albumin, bilirubin, and prothrombin time better reflect synthetic function than ALT or AST. The claim is vague and implies a general state of “sub-optimal” liver operation despite being told things are fine, but there is no strong evidence that people with normal standard tests commonly have clinically meaningful liver dysfunction absent other risk factors or symptoms. The index papers provided are not about liver assessment and do not support this liver-specific claim. Evidence and guidelines do support that some liver diseases can be missed by standard labs, but they do not support routine suspicion of hidden dysfunction in otherwise low-risk people with normal evaluation. Normal results can also simply reflect genuinely normal liver status, so the claim overgeneralizes a real limitation of testing. Mainstream hepatology recognizes that normal routine liver blood tests do not rule out all liver disease, especially early fibrosis, compensated cirrhosis, or some chronic conditions, but they do indicate that obvious biochemical injury or synthetic failure is not present. Current practice is to interpret liver tests in clinical context and use additional assessment only when symptoms, risk factors, or other findings justify it. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). Literature verdict: mixed.

Question 8

Is the claim "Hormones out of whack likely means liver function is not so great" supported by medical literature?

Accepted Answer

There is substantial evidence that chronic liver disease can cause multiple hormone abnormalities, particularly in advanced stages. Reviews of “hepatocrinology” and endocrine–liver interactions describe that cirrhosis disrupts metabolism, clearance, and regulation of sex hormones, thyroid hormones, adrenal hormones, and growth hormone, leading to systemic hormonal imbalance.[19] Chronic liver disease interferes with sex hormone metabolism and binding proteins, producing an elevated estrogen-to-testosterone ratio and hypogonadism in men.[17][19] The liver is central to thyroid hormone metabolism and conversion of T4 to T3; cirrhosis is frequently associated with low FT3, low FT4, and altered TSH, with abnormalities correlating with disease severity and outcomes.[12][13][14][18][23] These data support the idea that poor liver function is one important cause of hormone levels being “out of whack,” especially in established chronic liver disease.[19][21] Although liver dysfunction clearly can lead to hormonal disturbances, high‑quality evidence does not support a simple, general rule that any or most hormonal imbalance “likely” means liver function is poor. Current reviews emphasize a bidirectional relationship: many endocrine disorders (hypothyroidism, hypercortisolism, PCOS, hypogonadism, growth hormone deficiency) promote or worsen fatty liver disease, rather than liver disease being the primary driver of those endocrine problems in all cases.[4][6][21][23] Major endocrine abnormalities such as hypothyroidism, PCOS, diabetes, and adrenal disorders commonly occur with normal liver function and are independently diagnosed and managed; guidelines and reviews do not recommend assuming liver disease as the default cause of hormonal imbalance. Endocrine changes in cirrhosis are often nonspecific (euthyroid sick pattern, altered binding proteins), and similar lab patterns can occur in other systemic illnesses, so abnormal hormones are not a reliable standalone indicator of impaired liver function.[18][19][23] Overall, the evidence supports a complex, bidirectional interplay rather than the influencer’s one‑way, high‑probability causal claim. Mainstream medical and scientific opinion is that the liver and endocrine systems are tightly interconnected, and chronic liver disease frequently produces multiple hormone disturbances (thyroid, gonadal, adrenal, growth hormone, insulin) through impaired metabolism, clearance, binding proteins, and systemic inflammation.[19][21][23] Conversely, common endocrine disorders—such as hypothyroidism, hypercortisolism, PCOS, hypogonadism, and metabolic syndrome—can promote or exacerbate fatty liver and other chronic liver diseases.[4][6][21] Clinicians therefore evaluate both liver and endocrine function when abnormalities are found, but they do not treat hormonal imbalance as a reliable proxy for poor liver function; hormone changes have many potential causes and require direct assessment of liver status (history, examination, liver enzymes, imaging, and sometimes biopsy). The mainstream position is that hormonal imbalance can be a consequence or contributor to liver disease, but it does not, by itself, make impaired liver function “likely” without further evidence. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). Literature verdict: mixed.

Jaban M Moore alias Dr. Sub-Optimal Liver

Score breakdown

Key findings

Claims & evidence

Manipulation

Borrowed authority & guest funnel

Host self-funnel

Commerce & grift map

Credentials & scope

Permitted scope vs advertised

What this license permits

Validated associated properties

Analyzed

Funnel routes (third-party)

Tip the jar

Fight disinformation

Log a new mention

Reply snippets

Recent mentions (this doc)

Nudge the Doc Bro

Pick a contact address

What gets sent

Know someone who can help?

Who should we nudge?

What gets sent

Whambulance

Public challenge log

File a challenge

Citations